Navigation Links
LX211 highlighted as potential disease modifying therapy for non-infectious uveitis
Date:10/26/2009

ate and manageable. Abnormal hair growth (hirsutism) was observed in 5% of patients. Otherwise the safety profile was similar to placebo, and triglycerides and cholesterol were not elevated.

"Non-infectious uveitis involving the posterior segment of the eye is a leading cause of vision loss and long-term disability and the fourth leading cause of legal blindness in the industrialized world" said Ulrich Grau, Ph.D., Lux Biosciences' President and Chief Executive Officer. "As the majority of patients are first diagnosed at ages under 40 years, the socio-economic burden of uveitis is higher than that of other serious ocular conditions such as AMD and diabetic macular edema. The results from these clinical trials suggest that LX211 may have the potential to significantly change the face of uveitis therapy, based on its ability to modify the course of the disease. This is analogous to the advent of disease-modifying anti-rheumatic drugs (DMARD's) and their impact on the course of rheumatoid arthritis."


'/>"/>

Contact: Joan Kureczka
JKureczka@comcast.net
415-821-2413
Kureczka/Martin Associates
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Peregrines PS-targeting antibodies highlighted in AACR Annual Meeting studies
2. Agricultural research highlighted in Houston
3. Heat forms potentially harmful substance in high-fructose corn syrup
4. Iowa State University researcher uncovers potential key to curing tuberculosis
5. Mechanism for potential Friedreichs ataxia drug uncovered
6. The vasculature emerges as a potential therapeutic target in treating ADPKD liver cysts
7. National new biology initiative offers potential for remarkable and far-reaching benefits
8. Fear of insurance rejection deters potentially life saving genetic tests for bowel cancer
9. Time to tap climate change-combating potential of the worlds ecosystems
10. Time to tap climate-change-combating potential of the worlds ecosystems
11. UCSB scientists discover potential drug delivery system

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ed a protein that may help gut bacteria bind to th...d by probiotic producers to identify strains that ...obiotics need to interact with cells lining the gu...to surfaces in the gut they are more likely to sti...ys Dr Nathalie Juge from the Institute of Food Res...
(Date:11/24/2009)...November 24, 2009) -- The Wildlife Conservation So...t the last remaining population of Siberian tigers...ng tide of poaching and habitat loss. , ...fficials of what needs to be done to protect remai... The report was released by the Siberia...
(Date:11/24/2009)... in Spanish . , The presence of increased b...ry substances in the blood, hinders the loss and m...project of the University of Navarra conducted by ...l of Pharmacy. , The project, entitled "A nutrig...ontrol of body weight and inflammation," examines ...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2New strategy in tumor treatment 52140 1New strategy in tumor treatment 52140 2RI Hospital first in country to enroll patient in new study for recurrent chest wall breast cancer 52137 1RI Hospital first in country to enroll patient in new study for recurrent chest wall breast cancer 52137 2Breast cancer drug shows promise against serious infections 52134 1Breast cancer drug shows promise against serious infections 52134 2
... 2007 University of California, Irvine scientists...emory problems inherent in the most common form of...born and her colleagues identified how a mutated g...s from locking new memories into lasting ones. The...r1) -- is turned off in people with fragile X synd...
...vailabe in German . , In the ultimatum game -...h, now at the Max Planck Institute for Economics i...by an experimenter. That proposer can then divide ...responder. The responder is not powerless - if he ...fered amounts. But if he rejects it, both get noth...
...eads to under-consumption of calcium, according to...e the information consumed more. Researchers belie.... , A woman at risk for osteoporosis is told by he...every day. But when she looks at the Nutrition Fac...he finds that calcium is only listed by Percent Da...
Other Biology News:UCI researchers restore memory process in most common form of mental disability 2Fair play in chimpanzees 2Got calcium? UWM researcher finds that food labels confuse consumers 2Got calcium? UWM researcher finds that food labels confuse consumers 3
(Date:11/24/2009)...o also Visit Detroit , (V...French Ambassador for International Investment, an... , , , ,What: Ambassador Appia is available to me...atives adopted by France to further develop the fi...ion and development., , ,When: Available for Inter...
(Date:11/24/2009)...RNewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq:...heNasdaqStockMarketthattradinginthecompany,scommon...-NSEwillbefiledwiththe,SecuritiesandExchangeCommis...gonNasdaq,unlessthecompanyfilesanappealtotheNasdaq...anappeal,which,willstaythesuspensionanddelistingth...
(Date:11/24/2009)...a/--NODPharmaceuticalsInc.announced,theUSPatent&am...onfor,itsnano-particleoraldeliveryorNODtechnology....ncorporatepeptidesor,proteinsintobio-adhesivenano-...nisteredasinjections.NODtechnologyisaplatformtechn...hasinsulin,interferon,growthhormone,exenatide,hep...
(Date:11/24/2009)...ntly approved the Promega PowerPlex 16 HS System f...ing DNA records for the National DNA Index System....) -- The FBI recently approved the Promega PowerP...ticipating in, or generating DNA records for, the ...ontains more than seven million profiles and has a...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...ceutical Communication Event, Where Executives Ga...R &, Communications Summit for Pharmaceutical, Bi... Companies, NEW YORK, May 29 ExL Pharma ...e the participation of two keynote speakers from t...uring the 4th Annual Public,Relations and Communic...
...idates the critical role of self-care in...May 29 InterCure Ltd., a medical device,company p...E: INCR), today,announced its support of the new j...Association, American Society of Hypertension and ...declaring that people with,hypertension should rou...
...nch of Nine Emerging Therapies, Including Five Or... Resources, WALTHAM...rld,s leading research and advisory firms for phar...ighly anticipated launch of the first,oral agents ...e market,growth as these therapies, combined, will...
Other Biology Technology:FDA's Chief of Staff, Susan Winckler and Peter Thonis, Chief Communications 2FDA's Chief of Staff, Susan Winckler and Peter Thonis, Chief Communications 3InterCure Supports AHA Endorsement of Home Blood Pressure Monitoring 2InterCure Supports AHA Endorsement of Home Blood Pressure Monitoring 3Oral Drug From Novartis/Mitsubishi Tanabe Will Capture the Largest Market Share of All Emerging Multiple Sclerosis Therapies in 2017 2
Mouse Anti-Bovine Complex IV Monoclonal Antibody, Unconjugated, Clone 31E91B82G9 from MitoScience LLC
Rabbit Anti-gp120/160(SIV/mac239) Polyclonal Antibody, Unconjugated from Immune Technology
Rabbit Anti-GPCR TM7XN1 Polyclonal Antibody, Unconjugated from Abcam
Annexin V Binding Buffer from BD Biosciences Pharmingen
Biology Products: